Sennosides 8.6 mg Coated Tablets
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Amidon de maïs, Laque d'aluminium bleu FD&C No 2, Laque d'aluminium jaune FD&C No. 6, Croscarmellose de sodium, Lauryl sulfate de sodium, Stéarate de magnésium, Cellulose microcristalline, Talc, Dioxyde de titane, Dioxyde de silicium, Poly(éthylène glycol), Polyvinyl alcohol - part hydrolyzed, Laque d'aluminium FD&C Rouge n° 40
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Comprimé ; maximum: 3 Comprimé | 1 Tous les jours |
| Adolescentes | minimum: 12 years ; maximum: 18 years | minimum: 2 Comprimé ; maximum: 3 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
(Traditionally used in Herbal Medicine as a) stimulant laxative. (Used in Herbal Medicine for the) short-term relief of occasional constipation. (Used in Herbal Medicine to) promote(s) bowel movement (by direct action on the large intestine). (Used in Herbal Medicine as a) stimulant laxative to promote bowel movement and short-term relief of occasional constipation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Other names
- JAMP Sennosides Coated, JAMP Sennosides Enrobé
- Licence holder
- JAMP Pharma Corporation
- NPN or DIN-HM
- 80009182
- Status
- Active licence
- Licence date
- 28 January 2009
- Revision date
- 26 February 2024
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80009182
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.